- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02038270
Accuracy of Nexfin® and NIBP to Predict IBP
Evolution of the Accuracy of the Nexfin Pressure Signal Compared to Invasive and Noninvasive Arterial Blood Pressure
The Nexfin monitoring device relies on noninvasive pressure measurement using a finger-cuff manometer, combined with NIRS technology. The accuracy of the signal is dependent on the degree of vascular unloading, which takes an period before optimal unloading is reached. The evolution of the degree of inaccuracy caused by inclomplete unloading is quantified, and the absolute and relative inaccuracy of the nexfin as a function of the time is determined compared to the invasive blood pressure (IBP).
Secondly, the accuracy of the Nexfin to predict the IBP is compared with the accuracy of noninvasive blood pressure to predict the IBP.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Groningen, Netherlands, 9713EZ
- University Medical Center Groningen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients that are accepted for surgery
Exclusion Criteria:
- Patients unable or unwilling to provide consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
surgical patients
120 Adult patients, that are having a routine surgical procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
vascular unloading time
Time Frame: Start till end of operation
|
time to optimal vascular unloading
|
Start till end of operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bloodpressure
Time Frame: Start till end of operation
|
accuracy of nexfin compared to NIBP and IBP
|
Start till end of operation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alain Kalmar, dr, univertsity medical center groningen,university of groningen,the netherlands
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Nexfin_002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bloodpressure
-
Dr. Robert TanzolaCompleted
-
University Medical Center GroningenCompleted
-
Federal University of UberlandiaCompleted
-
Universitätsklinikum Hamburg-EppendorfCompletedFluid Overload | Bloodpressure | Volume Overload | Hemodynamic Rebound
-
University of California, San FranciscoSuspendedPilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD (PERFORMANCE)Hypertension | Chronic Kidney Disease | BloodpressureUnited States